A large number of peptides currently being marketed to the public are not FDA approved. These include BPC 157, LL 37, DSIP, Epitalon, GHK Cu (injectable), GHRP 2, GHRP 6, ipamorelin, kisspeptin 10, KPV, melanotan II, PEG MGF, MOTS C, Tesamorelin & Ipamorelin Peptide Therapy Fat Loss & GH Support BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee